Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Net Cash Flow (2019 - 2025)

Historic Net Cash Flow for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to $11.7 million.

  • Eton Pharmaceuticals' Net Cash Flow rose 35742.11% to $11.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.9 million, marking a year-over-year increase of 103200.66%. This contributed to the annual value of -$6.5 million for FY2024, which is 22693.29% down from last year.
  • Latest data reveals that Eton Pharmaceuticals reported Net Cash Flow of $11.7 million as of Q3 2025, which was up 35742.11% from $8.0 million recorded in Q2 2025.
  • Over the past 5 years, Eton Pharmaceuticals' Net Cash Flow peaked at $11.7 million during Q3 2025, and registered a low of -$8.3 million during Q4 2021.
  • Its 5-year average for Net Cash Flow is $796263.2, with a median of $823000.0 in 2022.
  • In the last 5 years, Eton Pharmaceuticals' Net Cash Flow soared by 2281250.0% in 2022 and then tumbled by 68079.18% in 2024.
  • Quarter analysis of 5 years shows Eton Pharmaceuticals' Net Cash Flow stood at -$8.3 million in 2021, then surged by 135.25% to $2.9 million in 2022, then crashed by 123.3% to -$682000.0 in 2023, then plummeted by 680.79% to -$5.3 million in 2024, then surged by 320.51% to $11.7 million in 2025.
  • Its Net Cash Flow was $11.7 million in Q3 2025, compared to $8.0 million in Q2 2025 and $2.5 million in Q1 2025.